2007 Heart-Brain summit proceedings

Cardiovascular autonomic dysfunction in patients with movement disorders

Benjamin L. Walter, MD

Center for Neurological Restoration, Neurological Institute,
Cleveland Clinic, Cleveland, OH

walterb@ccf.org

ABSTRACT

Autonomic dysfunction is common in parkinsonian syndromes, particularly those involving dysregulation of alpha-synuclein, and may result from neurodegeneration in autonomic regulatory regions of the brain or peripherial autonomic ganglia. The most limiting cardiovascular autonomic dysfunction in these diseases is orthostatic hypotension, which is particularly prominent in multiple system atrophy. Postprandial hypotension and supine hypertension, as well as dopaminergic therapy, often complicate the management of orthostatic hypotension in patients with parkinsonian syndromes.

CITATIONS

  1. Magalhaes M, Wenning GK, Daniel SE, Quinn NP.
    Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson’s disease—a retrospective comparison. Acta Neurol Scand 1995; 91:98–102.
    http://www.ncbi.nlm.nih.gov/pubmed/7785431

  2. Shy GM, Drager GA.
    A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. Arch Neurol 1960; 2:511–527.
    http://www.ncbi.nlm.nih.gov/pubmed/14446364
  3. Van der Eecken H, Adams RD, van Bogaert L.
    Striopallidal-nigral degeneration. An hitherto undescribed lesion in paralysis agitans. J Neuropathol Exp Neurol 1960; 19:159–160.
  4. Graham JG, Oppenheimer DR.
    Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969; 32:28–34.
    http://www.ncbi.nlm.nih.gov/pubmed/5774131
  5. Wenning GK, Geser F, Stampfer-Kountchev M, Tison F.
    Multiple system atrophy: an update. Mov Disord 2003; 18(Suppl 6):S34–S42.
    http://www.ncbi.nlm.nih.gov/pubmed/14502654
  6. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ.
    The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125:861–870.
    http://www.ncbi.nlm.nih.gov/pubmed/11912118
  7. McKeith IG, Dickson DW, Lowe J, et al.
    Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65:1863–1872.
    http://www.ncbi.nlm.nih.gov/pubmed/16237129
  8. Kraybill ML, Larson EB, Tsuang DW, et al.
    Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology 2005; 64:2069–2073.
    http://www.ncbi.nlm.nih.gov/pubmed/15985574
  9. Horimoto Y, Matsumoto M, Akatsu H, et al.
    Autonomic dysfunctions in dementia with Lewy bodies. J Neurol 2003; 250:530–533.
    http://www.ncbi.nlm.nih.gov/pubmed/12736730